Global Rabies Vaccine Market Insights, Forecast to 2025

  • ID:PD000922
  • August 2019
  • QY Research
                          

Rabies Vaccine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast period 2019-2025. The Global Rabies Vaccine  Industry Report gives an elaborate information about the market size, share and analyzes the complete value chain the report also covers the market dynamics enriching business strategists with quality data about the Rabies Vaccine  market.
 
This research report categorizes the global Rabies Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
 
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
 
Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With the implementation of China's two-child policy, downstream demand for rabies vaccine will not decrease in the coming few years.
 
Rabies vaccine is an irreplaceable product, so profile of rabies vaccine is very large. But due to its security requirements than the general drugs, the entire vaccine industry from R & D, production to distribution, sales and after-sales feedback link subject to very strict regulation. So, production companies are not as much as we imagined.
 
The most wildly used rabies vaccine is Vero cell rabies vaccine (VRV), which takes about 80.85% in 2016.Nowadays, global rabies vaccine production is mainly concentrated in China, Europe and North America. In 2016, China rabies vaccine production takes about 74.34% and Europe production takes about 7.46%.
 
In 2017, the global Rabies Vaccine market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Rabies Vaccine market based on company, product type, application and key regions.
 
The various contributors involved in the value chain of Rabies Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Rabies Vaccine include

  • GSK (Novartis)
  • Sanofi-Pasteur
  • Chengda
  • Yisheng
  • Prcmise
  • VACN
  • Changsheng
  • BCHT
  • Hissen
 
Market Size Split by Type
  • Vero Cell Rabies Vaccine
  • BHK
  • Chick Embryo Cell Rabies Vaccine
  • Other
 
Market Size Split by Application
  • Pre-exposure Prophylaxis
  • Post-exposure Prophylaxis
 
Market size split by Region
  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Singapore
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Central & South America
  • Brazil
  • Rest of Central & South America
  • Middle East & Africa
  • GCC Countries
  • Turkey
  • Egypt
  • South Africa
 
The study objectives of this report are:
  • To study and analyze the global Rabies Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
  • To understand the structure of Rabies Vaccine market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global Rabies Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Rabies Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To project the value and volume of Rabies Vaccine submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents - Guidelines
 1 Study Coverage
1.1 Rabies Vaccine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Rabies Vaccine Market Size Growth Rate by Type
1.4.2 Vero Cell Rabies Vaccine
1.4.3 BHK
1.4.4 Chick Embryo Cell Rabies Vaccine
1.4.5 Other
1.5 Market by Application
1.5.1 Global Rabies Vaccine Market Size Growth Rate by Application
1.5.2 Pre-exposure Prophylaxis
1.5.3 Post-exposure Prophylaxis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Rabies Vaccine Market Size
2.1.1 Global Rabies Vaccine Revenue 2016-2025
2.1.2 Global Rabies Vaccine Sales 2016-2025
2.2 Rabies Vaccine Growth Rate by Regions
2.2.1 Global Rabies Vaccine Sales by Regions
2.2.2 Global Rabies Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Rabies Vaccine Sales by Manufacturers
3.1.1 Rabies Vaccine Sales by Manufacturers
3.1.2 Rabies Vaccine Sales Market Share by Manufacturers
3.1.3 Global Rabies Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Rabies Vaccine Revenue by Manufacturers
3.2.1 Rabies Vaccine Revenue by Manufacturers (2016-2018)
3.2.2 Rabies Vaccine Revenue Share by Manufacturers (2016-2018)
3.3 Rabies Vaccine Price by Manufacturers
3.4 Rabies Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Rabies Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rabies Vaccine Product Category
3.4.3 Date of International Manufacturers Enter into Rabies Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Rabies Vaccine Sales by Type
4.2 Global Rabies Vaccine Revenue by Type
4.3 Rabies Vaccine Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Rabies Vaccine Breakdown Data by Application
6 North America
6.1 North America Rabies Vaccine by Countries
6.1.1 North America Rabies Vaccine Sales by Countries
6.1.2 North America Rabies Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Rabies Vaccine by Type
6.3 North America Rabies Vaccine by Application
6.4 North America Rabies Vaccine by Company
7 Europe
7.1 Europe Rabies Vaccine by Countries
7.1.1 Europe Rabies Vaccine Sales by Countries
7.1.2 Europe Rabies Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Rabies Vaccine by Type
7.3 Europe Rabies Vaccine by Application
7.4 Europe Rabies Vaccine by Company
8 Asia Pacific
8.1 Asia Pacific Rabies Vaccine by Countries
8.1.1 Asia Pacific Rabies Vaccine Sales by Countries
8.1.2 Asia Pacific Rabies Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Rabies Vaccine by Type
8.3 Asia Pacific Rabies Vaccine by Application
8.4 Asia Pacific Rabies Vaccine by Company
9 Central & South America
9.1 Central & South America Rabies Vaccine by Countries
9.1.1 Central & South America Rabies Vaccine Sales by Countries
9.1.2 Central & South America Rabies Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Rabies Vaccine by Type
9.3 Central & South America Rabies Vaccine by Application
9.4 Central & South America Rabies Vaccine by Company
10 Middle East and Africa
10.1 Middle East and Africa Rabies Vaccine by Countries
10.1.1 Middle East and Africa Rabies Vaccine Sales by Countries
10.1.2 Middle East and Africa Rabies Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Rabies Vaccine by Type
10.3 Middle East and Africa Rabies Vaccine by Application
10.4 Middle East and Africa Rabies Vaccine by Company
11 Company Profiles
11.1 GSK (Novartis)
11.1.1 GSK (Novartis) Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Rabies Vaccine
11.1.4 Rabies Vaccine Product Description
11.1.5 Recent Development
11.2 Sanofi-Pasteur
11.2.1 Sanofi-Pasteur Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Rabies Vaccine
11.2.4 Rabies Vaccine Product Description
11.2.5 Recent Development
11.3 Chengda
11.3.1 Chengda Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Rabies Vaccine
11.3.4 Rabies Vaccine Product Description
11.3.5 Recent Development
11.4 Yisheng
11.4.1 Yisheng Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Rabies Vaccine
11.4.4 Rabies Vaccine Product Description
11.4.5 Recent Development
11.5 Prcmise
11.5.1 Prcmise Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Rabies Vaccine
11.5.4 Rabies Vaccine Product Description
11.5.5 Recent Development
11.6 VACN
11.6.1 VACN Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Rabies Vaccine
11.6.4 Rabies Vaccine Product Description
11.6.5 Recent Development
11.7 Changsheng
11.7.1 Changsheng Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Rabies Vaccine
11.7.4 Rabies Vaccine Product Description
11.7.5 Recent Development
11.8 BCHT
11.8.1 BCHT Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Rabies Vaccine
11.8.4 Rabies Vaccine Product Description
11.8.5 Recent Development
11.9 Hissen
11.9.1 Hissen Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Rabies Vaccine
11.9.4 Rabies Vaccine Product Description
11.9.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Rabies Vaccine Raw Material
13.1.2 Rabies Vaccine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Insights, Forecast to 2025

Tigecycline Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Risperidone Market Insights, Forecast to 2025

Risperidone Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Caffeine Market Insights, Forecast to 2025

Caffeine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..